Hospital General Universitario de Alicante -ko ikertzaileekin lankidetzan egindako argitalpenak (10)

2023

  1. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

    Journal of Clinical Virology, Vol. 167

  2. Impact of potent nucleos(t)ide therapy on hepatitis B hospitalisations in Spain

    Alimentary Pharmacology and Therapeutics, Vol. 57, Núm. 5, pp. 540-548

  3. Impact of the COVID-19 pandemic on hospital admissions due to viral hepatitis in Spain

    Journal of Clinical Virology, Vol. 167

  4. Susceptibility to hepatitis B virus infection in adults living in Spain

    Liver International, Vol. 43, Núm. 5, pp. 1015-1020

  5. Treatment of hepatitis delta and HIV infection

    Liver International, Vol. 43, Núm. S1, pp. 108-115

2022

  1. Hepatitis C hospitalizations in Spain and impact of new curative antiviral therapies

    Journal of Viral Hepatitis, Vol. 29, Núm. 9, pp. 777-784

  2. Late presentation of human T-lymphotropic virus type 1 infection in Spain reflects suboptimal testing strategies: on behalf of the Human T-lymphotropic Virus (HTLV) Spanish Network

    International Journal of Infectious Diseases, Vol. 122, pp. 970-975

  3. Liver cancer and hepatic decompensation events in patients hospitalized with viral hepatitis in Spain

    Hepatology International, Vol. 16, Núm. 5, pp. 1161-1169

  4. Trends in hospitalizations and deaths in HIV-infected patients in Spain over two decades

    AIDS, Vol. 36, Núm. 2, pp. 249-256

2019

  1. HTLV-1 infection in solid organ transplant donors and recipients in Spain

    BMC Infectious Diseases, Vol. 19, Núm. 1